Ibrutinib tops chlorambucil against CLLJuly 10, 2019Leukemia, Myelodysplasia, TransplantationHematology
CNS-directed therapy appears more effective for synDLBCLJuly 9, 2019Lymphoma & Plasma Cell DisordersHematology
Cell count ratios appear to predict thromboembolism in lymphomaJune 25, 2019Lymphoma & Plasma Cell DisordersHematology
For tough AML, half respond to selinexor plus chemotherapyJune 25, 2019AMLLeukemia, Myelodysplasia, TransplantationHematology
Fixed-duration venetoclax-obinutuzumab superior to standard CLL therapyJune 7, 2019Leukemia, Myelodysplasia, TransplantationHematology
Daratumumab regimen shows benefit in transplant-ineligible myelomaMay 29, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersHematology
Genetic analysis identifies prognostic markers in CLLMay 28, 2019Leukemia, Myelodysplasia, TransplantationHematology
Lenalidomide may reduce risk of progression from SMM to MMMay 16, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersHematology
FDA approves venetoclax/obinutuzumab combo for CLLMay 15, 2019Leukemia, Myelodysplasia, TransplantationHematology
